Approximating the Operating Characteristics of Bayesian Uncertainty Directed Trial Designs.
暂无分享,去创建一个
Lorenzo Trippa | Steffen Ventz | Sandra Fortini | Marta Bonsaglio | L. Trippa | S. Fortini | S. Ventz | Marta Bonsaglio
[1] William F. Rosenberger,et al. Central limit Theorem for an Adaptive Randomly Reinforced Urn Model , 2015, 1502.06130.
[2] Li-Xin Zhang,et al. Central Limit Theorems of a Recursive Stochastic Algorithm with Applications to Adaptive Designs , 2016, 1602.05708.
[3] Donald A. Berry,et al. Bandit Problems: Sequential Allocation of Experiments. , 1986 .
[4] Lorenzo Trippa,et al. Bayesian response‐adaptive designs for basket trials , 2017, Biometrics.
[5] H. Kushner,et al. Stochastic Approximation and Recursive Algorithms and Applications , 2003 .
[6] William F. Rosenberger,et al. RANDOMIZED URN MODELS AND SEQUENTIAL DESIGN , 2002 .
[7] Lorenzo Trippa,et al. Bayesian Uncertainty Directed Trial Designs , 2018, Journal of the American Statistical Association.
[8] Peter Müller,et al. Bayesian Optimal Design for Phase II Screening Trials , 2008, Biometrics.
[9] Bradley P. Carlin,et al. Bayesian Adaptive Methods for Clinical Trials , 2010 .
[10] Robert L. Wolpert,et al. Statistical Inference , 2019, Encyclopedia of Social Network Analysis and Mining.
[11] Lorenzo Trippa,et al. Bayesian Baskets: A Novel Design for Biomarker-Based Clinical Trials. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Feifang Hu,et al. Asymptotics in randomized urn models , 2005 .
[13] D. Berry. Bayesian Statistics and the Efficiency and Ethics of Clinical Trials , 2004 .
[14] Jay Bartroff,et al. Approximate Dynamic Programming and Its Applications to the Design of Phase I Cancer Trials , 2010, 1011.6509.
[15] Michael Woodroofe,et al. Central Limit Theorems for Doubly Adaptive Biased Coin Designs , 1995 .
[16] C. Morris. Natural Exponential Families with Quadratic Variance Functions , 1982 .
[17] D. Berry,et al. Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. , 1995, Statistics in medicine.
[18] Benjamin Van Roy,et al. Learning to Optimize via Information-Directed Sampling , 2014, NIPS.
[19] D. Berry,et al. I‐SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy , 2009, Clinical pharmacology and therapeutics.
[20] Feifang Hu,et al. Efficient randomized-adaptive designs , 2009, 0908.3435.
[21] Donald A. Berry,et al. Modified Two-Armed Bandit Strategies for Certain Clinical Trials , 1978 .
[22] C. Assaid,et al. The Theory of Response-Adaptive Randomization in Clinical Trials , 2007 .
[23] Michael D. Smith,et al. Adaptive Bayesian Designs for Dose-Ranging Drug Trials , 2002 .
[24] C. Morris. Natural Exponential Families with Quadratic Variance Functions: Statistical Theory , 1983 .
[25] J. Wason,et al. A comparison of Bayesian adaptive randomization and multi‐stage designs for multi‐arm clinical trials , 2014, Statistics in medicine.
[26] Peter Müller,et al. A Bayesian Decision-Theoretic Dose-Finding Trial , 2006, Decis. Anal..
[27] Sophie Laruelle,et al. Randomized urn models revisited using Stochastic Approximation , 2011, 1101.2786.
[28] N. D’Esopo,et al. STREPTOMYCIN TREATMENT OF PULMONARY TUBERCULOSIS , 1998, The Journal of clinical investigation.
[29] P. Diaconis,et al. Conjugate Priors for Exponential Families , 1979 .
[30] Richard A. Johnson. Asymptotic Expansions Associated with Posterior Distributions , 1970 .
[31] Feifang Hu,et al. Asymptotic theorems for urn models with nonhomogeneous generating matrices , 1999 .
[32] Feifang Hu,et al. Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials , 2003 .
[33] L. J. Wei,et al. The Generalized Polya's Urn Design for Sequential Medical Trials , 1979 .
[34] Lorenzo Trippa,et al. Bayesian uncertainty‐directed dose finding designs , 2019, Journal of the Royal Statistical Society: Series C (Applied Statistics).
[35] Pierre Priouret,et al. Adaptive Algorithms and Stochastic Approximations , 1990, Applications of Mathematics.